STOCK TITAN

Darling Ingredients (NYSE: DAR) plans 2026 sale of award shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Darling Ingredients Inc. filed a notice of proposed sales of common stock under Form 144. The planned sales are to be effected through Citigroup Global Markets on or after 08/17/2026 on the NYSE. The shares relate to a stock option exercise granted in 2019–2021 and an employee stock award granted on 03/07/2023.

Positive

  • None.

Negative

  • None.
Shares from stock option net exercise 2,593 shares Common stock tied to stock option net exercise to be sold on or after 08/17/2026
Shares from employee stock award 3,876 shares Common stock from employee stock award granted on 03/07/2023 referenced in Form 144
Planned sale start date 08/17/2026 Date associated with proposed sales and stock option net exercise transactions
Form 144 regulatory
"Darling Ingredients Inc. filed a notice of proposed sales of common stock under Form 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Net Exercise financial
"2593 | 08/17/2026 | Stock Option Net Exercise Common Stock"
Employee Stock Award financial
"Common Stock | 03/07/2023 | Employee Stock Award | Darling Ingredients Inc."

FAQ

What does Darling Ingredients Inc. (DAR) disclose in this Form 144 filing?

Darling Ingredients Inc. discloses a proposed sale of common stock under Form 144. The shares are tied to a stock option exercise from grants in 2019–2021 and an employee stock award granted on 03/07/2023.

Which broker will handle the proposed Form 144 sales for Darling Ingredients (DAR)?

The proposed Form 144 sales will be handled by Citigroup Global Markets. The broker is identified with its New York address, and the sales are expected to take place on the NYSE after the disclosed date.

What types of equity awards underlie the Form 144 shares for DAR?

The Form 144 shares for Darling Ingredients Inc. arise from a stock option exercise granted on 1/29/2019, 1/29/2020, and 1/29/2021, and from an employee stock award granted on 03/07/2023, both classified as compensation-related equity.

When are the proposed Form 144 sales for Darling Ingredients (DAR) scheduled to begin?

The proposed sales are scheduled to begin on or after 08/17/2026. That date appears both in the securities information and in connection with the stock option net exercise, indicating the contemplated timing for the potential disposition.

How many Darling Ingredients (DAR) shares are tied to the reported awards in this Form 144?

The filing lists 2,593 shares related to a stock option net exercise and 3,876 shares related to an employee stock award. These figures represent the specific award-linked share amounts referenced in the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature